You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Umbrella study

Showing 26 - 50 of 388
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Early-stage Breast Cancer Trial in Heidelberg (Atezolizumab 1200 mg in 20 ML Injection, Inavolisib, Ipatasertib)

Not yet recruiting
  • Early-stage Breast Cancer
  • Atezolizumab 1200 mg in 20 ML Injection
  • +5 more
  • Heidelberg, Baden-Wuerttemberg, Germany
    National Center for Tumor Diseases
Sep 13, 2022

Esophageal Squamous Cell Carcinoma Trial (Paclitaxel, Irinotecan, Pembrolizumab)

Recruiting
  • Esophageal Squamous Cell Carcinoma
  • Chuo-ku, Tokyo, Japan
    National Cancer Center Hospital ( Site 3700)
Jan 31, 2023

Umbrella Trial in Relapsed Small Cell Lung Cancer Patients

Recruiting
  • Small Cell Lung Cancers
  • No treatment is included in this protocol.
  • Seoul, Korea, Republic of
    Se-Hoon Lee
Aug 26, 2021

Gastric and Gastroesophageal Junction Carcinoma Trial in China (Atezolizumab, Capecitabine, Oxaliplatin)

Recruiting
  • Gastric and Gastroesophageal Junction Carcinoma
  • Beijing City, China
  • +11 more
Jul 29, 2022

Follicular Lymphoma Stage II, Follicular Lymphoma Stage III, Follicular Lymphoma Stage IV Trial in Australia (BMS-986369,

Not yet recruiting
  • Follicular Lymphoma Stage II
  • +2 more
  • Ballarat, Victoria, Australia
  • +4 more
Mar 15, 2023

Oropharynx Squamous Cell Carcinoma, Larynx Squamous Cell Carcinoma, Hypopharynx Squamous Cell Carcinoma Trial in Brussels

Recruiting
  • Oropharynx Squamous Cell Carcinoma
  • +3 more
  • IO102
  • IO103
  • Brussels, Belgium
    Cliniques Universitaires Saint-Luc
May 6, 2022

Breast Cancer Trial (ARV-471, Abemaciclib)

Not yet recruiting
  • Breast Cancer
  • (no location specified)
Feb 1, 2023

Health, Subjective, Gastrointestinal Dysfunction, Cardiovascular Risk Factor Trial in Gig Harbor (dietary supplement,

Active, not recruiting
  • Health, Subjective
  • +6 more
  • Supplements and/or medical foods
  • +2 more
  • Gig Harbor, Washington
    Personalized Lifestyle Medicine Center
Apr 4, 2022

Squamous Cell Carcinoma of the Head and Neck Trial in Duarte, Portland (Atezolizumab, Tiragolumab, Immune-modulating

Recruiting
  • Squamous Cell Carcinoma of the Head and Neck
  • Duarte, California
  • +1 more
Aug 16, 2022

HIV Trial run by the NIAID (Interleukin-2)

Completed
  • HIV Infections
  • Bethesda, Maryland
    NIH Intramural Research Program ACTG CRS
Oct 28, 2021

Breast Cancer Trial in Fort Collins, Greeley, Loveland (vepdegestrant, Samuraciclib)

Not yet recruiting
  • Breast Cancer
  • Fort Collins, Colorado
  • +3 more
Nov 4, 2023

Breast Cancer Trial in Shanghai (A, B, CL1)

Recruiting
  • Breast Cancer
  • A
  • +8 more
  • Shanghai, Please Select, China
  • +1 more
Nov 27, 2021

Nasopharyngeal Carcinoma Trial in Guangzhou (sintilimab, Capecitabine)

Active, not recruiting
  • Nasopharyngeal Carcinoma
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Mar 17, 2022

HIV-1-infection Trial in United States (GS-5894, B/F/TAF, Standard of Care)

Recruiting
  • HIV-1-infection
  • Los Angeles, California
  • +15 more
Jan 13, 2023

Urothelial Carcinoma Trial in Worldwide (Zilovertamab vedotin)

Recruiting
  • Urothelial Carcinoma
  • Zilovertamab vedotin
  • Cleveland, Ohio
  • +11 more
Jan 25, 2023

Ovarian Cancer Trial in Denmark, Finland, Norway (Durvalumab, Tremelilumab, MEDI 9447, MEDI 0562)

Completed
  • Ovarian Cancer
  • Durvalumab, Tremelilumab, MEDI 9447, MEDI 0562
  • Vejle, Region Syddanmark, Denmark
  • +4 more
Jan 7, 2022

Platinum-resistant Recurrent Ovarian Cancer Trial in Seoul (olaparib+cediranib combination therapy, durvalumab + olaparib

Recruiting
  • Platinum-resistant Recurrent Ovarian Cancer
  • olaparib+cediranib combination therapy
  • +5 more
  • Seoul, Korea, Republic of
  • +2 more
Mar 29, 2021

Ovarian Cancer Trial in Wuhan (Pamiparib, Bevacizumab, Tislelizumab)

Not yet recruiting
  • Ovarian Cancer
  • Wuhan, Hubei, China
    Tongji Hospital of Tongji Medical College, Huazhong University o
Oct 6, 2021

Hearing Loss Trial in Australia, Belgium (Cochlear Implant and sound processor device fitting paradigm or diagnostic/measurement

Recruiting
  • Hearing Loss
  • Cochlear Implant and sound processor device fitting paradigm or diagnostic/measurement technique
  • Standard of care fitting or diagnostic measurement of Cochlear Implant and sound processor
  • Carlton, Victoria, Australia
  • +4 more
Feb 25, 2022

Breast Cancer Trial in United States (ARV-471, Ribociclib)

Not yet recruiting
  • Breast Cancer
  • Shiloh, Illinois
  • +8 more
Feb 1, 2023

Esophageal Squamous Cell Carcinoma (ESCC) Trial in Japan, Taiwan (Pembrolizumab, Coformulation favezelimab/pembrolizumab,

Recruiting
  • Esophageal Squamous Cell Carcinoma (ESCC)
  • Pembrolizumab
  • +5 more
  • Milan, Lombardia, Italy
  • +13 more
Jan 3, 2023

Precision Medicine for Colorectal Cancer Liver Metastasis Guided

Not yet recruiting
  • Colorectal Cancer Metastatic
  • Multi-omics
  • (no location specified)
Aug 24, 2020

Glioblastoma, Adult Trial in Germany (APG101, Alectinib, Idasanutlin)

Recruiting
  • Glioblastoma, Adult
  • Berlin, Germany
  • +12 more
May 20, 2022

Melanoma Trial in Worldwide (Nivolumab, Ipilimumab, RO7247669)

Recruiting
  • Melanoma
  • Duarte, California
  • +20 more
Jan 24, 2023

Targeted Pediatric High-Grade Glioma Therapy

Not yet recruiting
  • High Grade Glioma
  • +8 more
    • Aurora, Colorado
    • +17 more
    May 1, 2023